Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FULSZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,214
Award facts
- Contract value 100% obligated
- $34,214.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,214.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-set-aside contract represents a pharmaceutical delivery under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System, including military and veteran healthcare programs.
The delivery order falls within AmerisourceBergen's comprehensive Pharmaceutical Prime Vendor Global Program contract vehicle, which enables the company to supply an extensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare operations worldwide. Dupixent is a biologic medication commonly prescribed for conditions including atopic dermatitis, asthma, and eosinophilic esophagitis, reflecting the contractor's role in providing specialty pharmaceutical products to federal healthcare systems. This award demonstrates AmerisourceBergen's ongoing capacity to fulfill competitive federal procurement requirements for critical medical commodities supporting the Department of Defense and its beneficiaries.
Quick answers
Who was awarded contract SPE2DB26FULSZ?
SPE2DB26FULSZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FULSZ worth?
The government has obligated $34,214 on SPE2DB26FULSZ.
Is contract SPE2DB26FULSZ an order under another contract?
Yes. SPE2DB26FULSZ is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB26FULSZ competed?
The extent of competition for SPE2DB26FULSZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award